There is no single “good” eye pressure for everyone with glaucoma. Instead, doctors set a personalized target range based on how much damage has already occurred. A widely used framework puts the initial goal at 15–17 mmHg for mild glaucoma, 12–15 mmHg for moderate disease, and 10–12 mmHg for severe damage, with adjustments over time depending on age, baseline pressure, and whether vision loss continues.1PubMed Central. Simplifying “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma That range can feel vague if you are used to thinking of eye pressure as a simple pass-or-fail number, but the logic behind it is grounded in decades of clinical trial data and in the recognition that glaucoma is far more individual than a single cutoff can capture.
Why the Target Is a Range, Not a Number
If you have had your eye pressure checked, you may have heard that “normal” is somewhere below 21 mmHg. That threshold dates back to population averages, but it is not especially useful once you have a glaucoma diagnosis. Some people lose vision at pressures well below 21, while others tolerate pressures above it for years without damage. What matters after diagnosis is not where your pressure sits relative to a population average but whether it is low enough to stop your particular optic nerve from deteriorating further.
This is the idea behind target intraocular pressure. Your eye doctor picks a range they believe will halt or slow progression, then monitors you over months to see if the nerve and visual field remain stable. If they do not, the target gets revised downward. Factors that go into setting it include your baseline pressure before treatment, your age, how quickly damage appears to be progressing, and vascular factors like blood pressure that affect how well blood reaches the optic nerve.1PubMed Central. Simplifying “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma The target is always provisional. It gets reassessed every six to twelve months based on how your eyes respond.
What the Major Trials Actually Showed
Two landmark studies shaped how clinicians think about pressure targets. The Early Manifest Glaucoma Trial found that treatment reducing IOP by about 25 percent from baseline led to meaningfully slower progression. In that trial, the treated group progressed less often than the untreated controls, and when progression did happen, it occurred later.2PubMed. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial The practical takeaway was clear: even a modest sustained reduction in pressure protects the nerve.
The Advanced Glaucoma Intervention Study pushed the point further. Eyes that kept their pressure below 18 mmHg at every single visit over six years showed essentially zero worsening of their visual fields, while eyes that exceeded 18 mmHg at more than half of visits showed significant decline over seven years.3American Journal of Ophthalmology. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration Aggressive pressure lowering to a mean of around 12 mmHg in that study was associated with no measurable progression at all.4Optometric Education. Targeting Intraocular Pressure in Glaucoma These results are why doctors treating advanced glaucoma often push for the low teens or even single digits, accepting the added treatment burden that comes with more aggressive goals.
How Corneal Thickness Can Fool the Reading
One of the more frustrating realities of eye pressure measurement is that the most common method, Goldmann applanation tonometry, is sensitive to the thickness of your cornea. A thinner-than-average cornea will give an artificially low pressure reading, making things look safer than they are. A thicker cornea does the opposite, making pressure look higher than it truly is.5PubMed Central. Central Corneal Thickness and Glaucoma Risk: The Importance of Corneal Pachymetry in Screening Adults Over 50 and Glaucoma Suspects
This is not a small effect. In a large population study, people with thin corneas showed the steepest rise in glaucoma prevalence as measured pressure went up, while those with thick corneas showed the gentlest rise. Once researchers corrected for corneal thickness, the differences between the groups largely disappeared.6PubMed Central. Intraocular Pressure, Central Corneal Thickness, and Prevalence of Open-Angle Glaucoma: The Los Angeles Latino Eye Study In practical terms, this means some people with glaucoma walk around with readings that look “normal” simply because their corneas are thin, while some people flagged as having high pressure never develop glaucoma because their thick corneas inflated the reading.
If you have not had a corneal thickness measurement (called pachymetry), it is worth asking about, especially if your pressure readings seem inconsistent with your level of nerve damage. Knowing your corneal thickness gives your doctor a correction factor that makes the target IOP more meaningful. Some newer tonometers, such as dynamic contour devices, are less affected by corneal thickness, though even those are not completely immune to it.7PubMed. Effect of central corneal thickness on dynamic contour tonometry and Goldmann applanation tonometry in primary open-angle glaucoma
Normal-Tension Glaucoma Changes the Conversation
The target-pressure framework gets more complicated when pressure was never high to begin with. In normal-tension glaucoma, damage happens even though IOP sits in the statistically normal range, typically below 21 mmHg. For these patients, the idea of lowering pressure “by 25 percent” can mean pushing into the single digits, which is harder to achieve and raises the risk of side effects from aggressive treatment.
The original Collaborative Normal-Tension Glaucoma Study reported a benefit from pressure lowering, but a recent methodological reassessment raised questions about how robust that finding really was. The study shifted the starting point for its analysis in the treatment group, which excluded early progression events and introduced a form of statistical bias. Under the original analytical plan, the treatment benefit was not statistically significant.8PubMed Central. Reassessment of the Collaborative Normal-Tension Glaucoma Study: Statistical Evidence and Implications for Current Management This does not mean lowering pressure is useless in normal-tension glaucoma, but it does mean the evidence is less airtight than many patients assume. Doctors still generally aim for around a 30 percent reduction from baseline, but they pay more attention to other risk factors, including blood flow to the optic nerve.
Blood pressure matters here in a way that surprises some people. Low ocular perfusion pressure, essentially the gap between your blood pressure and your eye pressure, has been associated with roughly a 50 percent higher risk of glaucoma progression.9Current Opinion in Ophthalmology. Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings If your blood pressure drops too low (sometimes from overly aggressive treatment for hypertension), the optic nerve gets squeezed from both sides: the eye pressure pushing in and inadequate blood flow failing to push back. For someone with normal-tension glaucoma or borderline blood pressure, this balance is especially delicate.
Angle-Closure Glaucoma Has Different Mechanics
Most discussion of target IOP centers on open-angle glaucoma, which accounts for the majority of cases. Angle-closure glaucoma involves a physically narrowed or blocked drainage pathway, and treatment often addresses the structural problem directly. In primary angle-closure disease, imaging of the front of the eye shows that narrower drainage angles are linked to higher pressures.10PubMed Central. Quantitative Assessment of Anterior Segment OCT Parameters and Their Association with Intraocular Pressure in Primary Angle-Closure Disease
Cataract surgery alone can significantly help in these cases. Removing the natural lens deepens the front chamber of the eye and widens the drainage angle, producing an average pressure reduction of about 20 percent. The higher the pressure was before surgery, the bigger the drop afterward.11PubMed. Preoperative Factors Correlating With Intraocular Pressure Reduction After Phacoemulsification in Primary Angle Closure Glaucoma Angle-closure patients who need additional treatment still work toward the same severity-based target ranges, but the fact that a structural fix can deliver a large portion of the reduction means the medical burden is sometimes lighter than in open-angle disease.
Pressure Fluctuates More Than You Might Think
Your eye pressure is not a fixed number. It shifts throughout the day, typically peaking in the early morning and dipping in the afternoon, though patterns vary. The reading you get at a 2 p.m. office visit might be several points lower than what your eye experiences at 5 a.m. Whether these day-to-day and hour-to-hour swings independently drive glaucoma progression remains an open question; the research is mixed and the topic stays controversial.12PubMed Central. Intraocular Pressure Fluctuation: Is It Important?
Still, fluctuation matters clinically even if its independent role is unclear. If your pressure looks good at every daytime visit but spikes overnight, your doctor might underestimate how much stress the nerve is under. Some patients whose disease keeps progressing despite apparently good clinic readings have been found to have large pressure swings outside the office. Continuous monitoring devices, including a contact lens sensor that tracks pressure-related changes over 24 hours, are being developed to catch exactly this problem.13PubMed Central. The Application of a Contact Lens Sensor in Detecting 24-Hour Intraocular Pressure-Related Patterns A newer version of such a sensor has shown good agreement with standard office measurements in both seated and lying-down positions, which is encouraging for future clinical use.14PubMed Central. A Novel Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Accuracy in Human Eyes
Getting to Target: Drops, Laser, and Surgery
First-line treatment is usually either medicated eye drops or laser trabeculoplasty. Among drops, prostaglandin analogs are the most commonly prescribed class, and the various formulations available perform similarly in their ability to lower pressure, though there can be minor differences in side-effect profiles.15PubMed. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences Prostaglandin analogs outperform older drug classes like beta-blockers and carbonic anhydrase inhibitors when used alone.16PubMed Central. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension
Selective laser trabeculoplasty has emerged as a genuine alternative to starting with drops. In a major trial comparing the two approaches, about 95 percent of eyes in the laser group were at target pressure at three years, and roughly three-quarters of patients in that group remained completely free of daily eye drops during the study period.17PubMed Central. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial Over three years, the laser group was also more consistently within target range at clinic visits and none of those patients needed glaucoma surgery, compared to eleven in the drops-first group.18PubMed Central. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT The practical advantage is obvious: no daily medication routine, fewer side effects, and no concerns about whether you are using the drops correctly.
When drops and laser are not enough, surgical options come into play. Traditional trabeculectomy remains the most powerful IOP-lowering procedure and achieves target pressure in a larger share of patients than newer, less invasive procedures. However, it also carries a higher risk of complications like excessively low pressure afterward. Newer minimally invasive glaucoma surgeries offer a gentler option with fewer complications, though they may not lower pressure quite as aggressively.19Journal of Neonatal Surgery. Long-Term Outcomes of Microinvasive Glaucoma Surgery (MIGS) vs. Trabeculectomy The choice between them often depends on how much pressure reduction you need to reach target.
The Adherence Trap
Here is something that does not get talked about enough: many people with glaucoma never reach their target pressure, not because their treatment is inadequate on paper, but because they do not use their drops consistently. The drops do not hurt, the disease does not produce symptoms until late stages, and the daily routine is easy to forget. When this happens, a doctor may see an underwhelming response at the next visit and add a second or third medication, creating a more complicated regimen that makes adherence even harder.20PubMed Central. Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Research backs up the intuition that inconsistency matters. People with lower adherence show a measurable correlation with faster glaucoma progression and are also more likely to stop showing up for follow-up appointments altogether.21Scientific Reports. The association between glaucoma treatment adherence with disease progression and loss to follow-up If your pressure readings bounce around between visits and your doctor seems frustrated, an honest conversation about how often you actually use the drops is more productive than adding another bottle. This is also one reason the laser-first approach has gained ground: it takes adherence out of the equation entirely for many patients.
Exercise, Posture, and Everyday Pressure Spikes
Everyday activities can bump your eye pressure up temporarily. Physical exercise, changes in body position, and especially anything involving straining or holding your breath (the Valsalva maneuver) can raise IOP, sometimes substantially.22PubMed Central. Intraocular pressure and glaucoma: Is physical exercise beneficial or a risk? Heavy weightlifting with breath-holding, inverted yoga poses, and playing high-resistance wind instruments are commonly flagged situations. Aerobic exercise, on the other hand, tends to lower pressure transiently.
These acute spikes are usually short-lived, and moderate exercise is generally considered beneficial. But if you are someone whose target pressure is in the low teens or single digits, repeated large spikes could matter over time. The practical advice is straightforward: keep exercising, favor aerobic activity, breathe normally during resistance training, and avoid prolonged head-down positions. If you play a brass instrument or do inversions in yoga, mention it to your eye doctor so they can factor it into your monitoring plan.
When Your Pressure Looks Good but Things Get Worse Anyway
Glaucoma is fundamentally a disease of the optic nerve, and pressure is its most treatable risk factor but not its only one. The optic nerve head contains supportive cells and a structural scaffolding that respond to pressure, but also to inadequate blood supply and other biochemical stresses.23PubMed Central. Understanding mechanisms of pressure-induced optic nerve damage Some people hit their pressure target perfectly yet still progress, and researchers are actively searching for treatments that protect the nerve through non-pressure pathways.
If you are in this situation, your doctor may recheck your corneal thickness to make sure your readings are accurate, order 24-hour pressure monitoring to look for hidden spikes, evaluate your blood pressure for overnight dips, and repeat imaging of the nerve at shorter intervals. A “good” pressure that does not prevent further damage is, by definition, not yet low enough, and the target gets revised downward. In some cases, though, further pressure lowering is either impractical or does not help, and the search shifts to factors beyond IOP. This remains one of the more difficult frontiers in glaucoma care, and it is the main reason researchers are investigating neuroprotective strategies that work independently of eye pressure.
How Pressure Measurement Has Changed Over the Decades
The ability to measure eye pressure at all is relatively recent in medical terms. The first instrument for measuring it appeared in 1865. A reasonably accurate applanation device came along later in the nineteenth century, and an indentation-style tonometer dominated clinical practice for much of the twentieth century. The Goldmann applanation tonometer, introduced in 1950, ushered in the era of truly accurate measurement and remains the reference standard today.24PubMed Central. A history of intraocular pressure and its measurement The fact that it is still the gold standard after more than 70 years is both a testament to its accuracy and a reminder of the field’s hunger for something better, especially given the corneal thickness problem already discussed. Handheld rebound tonometers are now common in clinics and allow home monitoring, but they introduce their own variability and are not yet a routine replacement for the office visit.